ArticleJournal of neuropathology and experimental neurology2025

Merlin immunoreactivity fails to predict neurofibromatosis type 2 mutations in human meningiomas.

Sofie Eline Tollefsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.